Discover the Science of Health
A nationally representative survey shows that natural product use in the United States has shifted since 2007, with some products becoming more popular and some falling out of favor. Overall, natural products (dietary supplements other than vitamins and minerals) remain the most common complementary health approach.
Between 1996 and 2007, use of herbal supplements in the U.S. rose by a staggering 83% [1]. Many people use herbal medicines mistakenly believing them to be safe simply because they are ‘natural’. However, just like conventional drugs, herbal medicines alter normal body physiology. And despite their wholesome image, many herbal products have adverse effects and may have dangerous interactions with other drugs and dietary supplements. New research published in BioMed Central’s open access journal BMC Medicine reveals that most over-the-counter herbal products do not contain any of the key information required for safe use [2].
A new online resource, designed to give health care providers easy access to evidence-based information on complementary and alternative medicine (CAM), was unveiled recently by the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health. With this new resource, providers will have the tools necessary to learn about the various CAM practices and products and be better able to discuss the safety and effectiveness of complementary and alternative medicine with their patients.
Welcome to the 7th edition of the Cancer Research Blog Carnival, a blog carnival devoted to cancer research. This edition includes some great articles on cancer research ethics, cancer therapeutics, cancer stem cells, cancer genetics and cancer biology.
I believe it’s important to maintain perspective on the significance of cancer research and the impact it has on patients. As such, this months edition of the Cancer Research Carnival includes narratives from some people affected by the disease. I think their stories will inspire us all with their determination and courage, and serve as motivation to continue searching for therapies to combat cancer.
A new U.S. Food and Drug Administration (FDA) docket was published on the FDA website last month. The draft guidance, when finalized, will represent the FDA’s current thinking on complementary and alternative medicine (CAM). Docket No. 2006D-0480: Draft Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration [1] discusses when a CAM product is subject to the Federal Food, Drug, and Cosmetic Act (the Act) or the Public Health Service (PHS) Act.
